SLC25A1 and glioblastoma: Therefore, we downregulated the expression of SLC25A1 by siRNA-technology (RNAi) (Fig. S1a) and determined the effects on D-2-HG levels in lung (A549, NCI-H460) and glioblastoma (U87-MG, T98G) cell lines as described previously [19].